Patent Filing

Forma Medical’s newly patented MIPA technique adapts trauma surgery principles to elective joint fusion, creating a formidable IP moat in orthopedic care.

Quantum X Labs claims a 21-fold error reduction on IBM processors, but can a hybrid company balancing ad tech and quantum deliver on its promises?

NuCana's new European patent for its cancer drug NUC-7738 strengthens its global IP moat, backing its clinical push against PD-1 resistant melanoma into 2029.

By leveraging deuterated chemistry, Aviva Bio aims to bypass the oncologic risks that have stalled FDA approval for female testosterone therapies for decades.

Foot Levelers’ new patented Nexi pillow isn't just a product; it's a strategic move to medicalize sleep, using AI and 3D scans to fight modern ills like 'tech neck'.

A Michigan biotech just patented a way to turn yeast into tiny drug factories inside you. It’s a blueprint for a future without injections or cold chains.

With new patents in Australia and Japan, Leveragen isn't just protecting its tech. It's building a data-rich biological engine for AI-driven medicine.

A new US patent allowance for Purple Biotech's modular CAPTN-3 platform bolsters its strategic position, promising safer, more precise antibody cancer treatments.

With a new patent, a bold asset pivot, and a top-tier banking partner, PharmAla Biotech is signaling a new phase of commercial maturity in psychedelic medicine.

A new patent for an 'evolving' digital ID promises to fight fraud and boost financial inclusion. But what does a continuous identity profile mean for us?

A New Hampshire firm just patented a high-tech vacuum. It seems mundane, but it reveals a deep strategy for dominance in advanced manufacturing.

A new patent for its E-Motion™ powertrain isn't just about IP; it's a strategic move to lock down safety, secure OEM deals, and define the future.

A new composition of matter patent extends protection for Alterity's lead drug to 2045, de-risking its path in MSA and opening a new front against Parkinson's.

A new patent allows securities to exist as both ETF shares and digital tokens, with giants like HSBC already on board. Is this the end of digital chaos?

With new patents and a $300M war chest, Beren Therapeutics nears an FDA decision for its NPC drug. But can its public benefit model survive the high-risk biotech gauntlet?

A Mobile startup’s fourth patent for a surgical device isn't just an innovation; it's proof that Alabama's strategic investment in tech is building a new economy.

Proto Inc.'s new design patent for its M hologram unit is more than just IP. It's a strategic move to define the form factor for a new era of work.

New patents in Europe and Australia grant Savara long-term protection for a vital new therapy, offering hope to patients with a rare, debilitating lung disease.

Two small firms just secured a patent until 2045 on a decades-old drug. It's a masterclass in strategy, revealing the future of pharmaceutical value.

Pilot Games' new patent for e-pull-tabs isn't just a tech upgrade; it's a strategic move in a billion-dollar market where IP is the ultimate jackpot.